First Ebola Vaccine Among Seven Products To Get EMA Nod
WHO’s Prequalification Of Ervebo Will Support Its Rapid Roll Out
Executive Summary
Seven new products, including the world’s first ever Ebola vaccine, are on track to receive EU-wide approval. Meanwhile, two drugs have failed to make the grade.
You may also be interested in...
Novartis, D&A Pharma Prepare For High-Stake EMA Meetings
Oral explanation meetings are due to take place this week for drug sponsors who have a final chance to address questions and concerns the European Medicines Agency has about their marketing applications.
EU 2019 Approvals: Novel Therapies Make Strong Showing
Bluebird bio’s gene therapy Zynteglo, Akcea’s antisense drug Waylivra and BioMarin’s enzyme substitution therapy Palynziq were among the novel innovative medicines that were approved in Europe in 2019.
Last-Minute Pushback On Janssen’s EU Spravato Approval
What is in store for esketamine after third parties submit written interventions to the European Medicines Agency?